) is not only an oxidative product of nitric oxide (NO), but also serves as an indicator of endothelial nitric oxide synthase activity and as a circulating reservoir of NO bioactivity in the circulatory system. [1] [2] [3] The indicator status is supported by observations that approximately 70-90% of circulating plasma NO 2 Ϫ levels derive from NO produced by endothelial nitric oxide synthase. 4, 5) The reservoir activity is widely accepted (see reviews [1] [2] [3] ) as is maintained when NO 2 Ϫ reacts with deoxygenated hemoglobin (Hb) in red blood cells (RBCs) to form NO and methemoglobin (metHb), leading to biological responses including vasodilation.
Ϫ plasma levels, including detailed kinetic knowledge, is required for further understanding of NO 2 Ϫ biology in the circulation. However, only limited kinetic data [8] [9] [10] are presently available, and many problems of NO 2 Ϫ biology await resolution.
For example, it is still controversial whether arterio-venous (A-V) differences in plasma NO 2 Ϫ levels actually exist. [10] [11] [12] [13] [14] [15] [16] The A-V difference may reflect consumption of NO 2 Ϫ to form NO during peripheral circulation for preservation of blood flow at lower oxygen tension. 12) Although we have previously reported a small but significant A-V difference under steadystate conditions, 10, 14, 17) these observations are complicated by a report that, in isolated blood, uptake of NO 2 Ϫ by RBCs is faster in venous blood than in arterial blood, 15) a scenario that may cause artificial apparent A-V differences when arterial and venous blood samples are treated after some delay. If this situation is indeed the case, our previous work reporting kinetic parameters 10) should also be re-evaluated. It is also unclear whether plasma NO 2 Ϫ levels reflect in vivo changes in NO 2 Ϫ levels. 10, 12, 18) Exogenously administered NO 2 Ϫ or NO resulted in a large A-V difference in plasma NO 2 Ϫ , with arterial blood preferentially reflecting the changes, 10, 14, 17) presumably due to greater contributions by RBCs or tissue as a buffering compartment under a state of lower oxygenation. A possible difference in the uptake rate of RBCs could not be large enough to explain such a large A-V difference, and contributions of tissue factors would be a great concern. 18, 19) The emerging role of tissue as a reservoir of NO bioactivity via NO 2 Ϫ should be taken into consideration; some reports indicate that plasma NO 2 Ϫ levels may not accurately reflect increases in NO or NO 2 Ϫ levels in biological systems. 3, 20, 21) However, no alternative measures exist for assessing NO bioactivity in easily accessible biomaterials (such as blood). Therefore, the aim of this study was to estimate the steady-state concentration of plasma NO 2 Ϫ in order to evaluate whether the putative A-V difference actually exists. We also re-evaluated the pertinent kinetic features in vivo, considering uptake by RBC and tissue factors.
MATERIALS AND METHODS
Japanese white rabbits weighing 2.4-3.5 kg were anesthetized with intravenous sodium pentobarbital (30 mg/kg). Cannulae were inserted into the jugular vein (for drug administration), the carotid artery (to monitor blood pressure), the femoral vein, and the femoral artery (for blood sampling). A tachometer to measure pulse rate was triggered by pulse waves of arterial pressure. Experimental procedures were performed after a stabilization period of 20-60 min. When required, several minutes were allowed to elapse for the recovery of hemodynamic parameters after the initial control blood sampling. Sprague-Dawley rats (250-350 g) and Hartley guinea pigs (300-400 g) were anesthetized by intraperitoneal injection of pentobarbital (0.16 ml/100 g of 30 mg/ml solution) or urethane (0.6 ml/100 g of 25% solution), respectively. Cannulation and preparation were performed as described above.
The Ethics Committee of Kanazawa Medical University approved all animal procedures, and the animals were treated under conditions set forth in the "Guiding Principles for the Care and Use of Laboratory Animals" of the Japanese Pharmacological Society.
Ex Vivo Study of NO 2 ؊ ؊ Disappearance from Plasma For monitoring the ex vivo disappearance of endogenous and exogenous NO 2 Ϫ from plasma, arterial and venous blood (6 ml each) were sampled from rabbits with syringes containing heparin sheets taken from vacuum blood sampling tubes (Venoject II/VP-H050K, Terumo, Tokyo, Japan). The blood samples were transferred to 25-ml conical tubes. After ex vivo addition of vehicle (60 ml saline; protocol A) or NaNO 2 (60 ml of 600 mM solution; final concentration in whole blood is expected to increase by 6 mM; protocol B), the samples were gently stirred by rolling (Wave rotor WR-40, Thermonics Co., Ltd., Tokyo, Japan) for 10 s. The blood samples were then equally divided among 6 microcentrifuge tubes, which were capped after flashing the headspace with argon gas. Every microcentrifuge tube was kept at 37°C before sample processing. At the desired time points, the samples were stirred by inversion, the whole-blood NO 2 Ϫ and nitrate (NO 3 Ϫ ) measurement (NO x ) was taken, and the remaining sample was centrifuged (3300ϫg for 30 s at 4°C) to separate the plasma.
For monitoring the ex vivo disappearance of NO 2 Ϫ from plasma after in vivo exogenous NO 2 Ϫ administration, after control blood was sampled from the anesthetized rabbit, 500 nmol/kg of NaNO 2 (0.1 ml/kg of 5 mM NaNO 2 in saline) were infused intravenously. Arterial and venous blood samples (6 ml each) were taken after 30 s, equally divided among 6 microcentrifuge tubes, and treated as described above (protocol C).
In Vivo Kinetic Study To examine the kinetic properties of plasma NO 2 Ϫ , 500 nmol/kg of NO 2 Ϫ were injected (0.1 ml/ kg of 5 mM NaNO 2 in saline) into the anesthetized rabbits, and arterial and venous blood samples were taken at the desired time points.
For quantification of plasma NO 2 Ϫ , plasma NO 3
Ϫ
, and hemolysate NO x levels, an initial blood specimen (ca. 0.5 ml) was used to wash the sampling route (including the syringe), and was discarded to avoid possible contamination of subsequent blood specimens. Samples (1.5 ml each) were then taken of arterial and venous blood; after each sampling procedure, an equivalent volume of saline was infused to compensate for the lost blood. The saline NO 2 Ϫ and NO 3 Ϫ levels were below 50 nM in every experiment, and a preliminary study revealed that the plasma NO 2 Ϫ and NO 3 Ϫ concentrations were not significantly affected by this saline supplementation (data not shown).
Similar protocols were applied for metHb determinations and nitrosothiol (R-SNO) explorations in plasma (see below).
Ex Vivo Changes in NO 2 ؊ ؊ Concentration under Different Blood Oxygenation States Rabbit arterial and venous blood samples (5.4 ml each) were drawn from catheters into disposable syringes including heparin sheets, then divided into two plastic conical tubes (2.7 ml/5 ml tube). After 1.0 ml of whole blood was removed for control measurements of whole-blood NO x and plasma NO x levels, the tubes were capped and gently rolled (for 10 min, at room temperature) to stir and to equilibrate the blood samples with the headspace gaseous phase (argon gas or room air with or without addition of 0.2-0.5 ml oxygen). The condition of the equilibration was set by a preliminary experiment. Blood gas profiles were analyzed before and after the treatments described below (0.3-0.7 ml).
NO 2 ؊ ؊ and NO 3 ؊ ؊ Measurements Blood samples were immediately transferred to prewashed microcentrifuge tubes (1.5 ml; QSP, Porex Bio Products Group, Petaluma, CA, U.S.A.) containing a heparin sheet (one-quarter). After centrifugation (3300ϫg for 30 s at 4°C), plasma was mixed with methanol (1 : 1) and centrifuged (10000ϫg for 10 min at 4°C) to remove proteins. The supernatants were immediately used for NO 2 Ϫ (and NO 3 Ϫ ) analysis in every experiment. Sample treatment for NO x measurement in whole blood (see below) was performed concurrently. Both arterial and venous blood samples (50 ml) were transferred to 450 ml of 10 mM Tris buffer (pH 7.4) to cause hemolysis. After centrifugation (10000ϫg for 10 min at 4°C), the supernatant was directly used for NO x determination as described elsewhere. 22) We determined NO x levels using an HPLC-Griess system (ENO10 and ENO20; Eicom, Kyoto, Japan) consisting of a separation column, a flow reactor (with Griess reagent), a reduction column, and a detector at 540 nm, as described elsewhere. 13) Operating under default conditions, the detection limit and sensitivity was 0.1 mM for both NO 2 Ϫ and NO 3 Ϫ with a loading volume of 10 ml. When we removed the reduction column and increased the loading volume to 100 ml, the sensitivity and detection limit for NO 2 Ϫ improved to 1 nM and 2 nM, respectively. 10, 14) Special attention was paid to exclude possible sources of NO 2 Ϫ and NO 3 Ϫ contamination during the entire procedure. Unless otherwise specified, all laboratory wares were washed five times with pure water (resistance above 18.3 MW and almost completely free of NO x contamination; MILLI-Q SP, Millipore, Bedford, MA, U.S.A.) to minimize NO 2 Ϫ and NO 3 Ϫ contamination. 14, 23) Hb and metHb Measurements Arterial and venous blood (0.6 ml each) were sampled with syringes equipped with heparin sheets, and 10 ml was used to determine total Hb levels. Photometric quantification of Hb content was performed using the Hemoglobin B-test Wako (SLS-hemoglobin method; Wako Pure Chemical Industries, Osaka, Japan) according to the manufacturer's instructions. A blood aliquot (0.4 ml) was lysed in pure water (16 ml) , and the metHb fraction was determined by the Evelyn-Malloy (KCN addition) method, 24) with modifications. S-Nitrosothiols (R-SNOs) Measurement Fresh blood samples (2.5 ml) were immediately mixed with ethylenediaminetetraacetic acid-2Na (3.2 mM final concentration) and N-ethylmaleimide (8 mM final concentration) to prevent R-SNO decay. Blood samples (1.0 ml) were filtered by Centrisart I (cut-off 10 kDa, Sartorius, Göttingen, Germany; 1800ϫg for 5 min at 4°C); the levels of S-nitrosocysteine and Snitrosoglutathione, low molecular weight R-SNOs, were determined in 100 ml of the filtrate by HPLC-Saville's method (Eicom). The sensitivity and detection limit was 1-2 nM for both S-nitrosocysteine and S-nitrosoglutathione. 25) S-Nitrosoalbumin, a high molecular weight R-SNO, was determined by HPLC-Saville's method 26) with modifications improving the detection limit and the sensitivity to 5 nM. After centrifugation of the blood (1800ϫg for 5 min at 4°C), large plasma particles were removed with a 0.2-mm filter (Milex-LG, Millipore); the filtrate (200 ml) was applied to the HPLCSaville's system.
Blood Gas Analysis Blood gas profiles were analyzed with GASTAT-3 (Techno Medica Co., Ltd., Yokohama, Japan) with heparinized whole blood.
Kinetic where Y is the NO 2 Ϫ concentration above steady-state, YЈ is the real NO 2 Ϫ concentration, A is the estimated concentration of the distribution phase at time 0, and B is the estimated concentration of the elimination phase at time 0. a and b are the apparent elimination constants of the distribution phase and the elimination phase, respectively, and t is the time after administration. Data were fitted to the theoretical equation and hybrid parameters such as A, B, a, and b were estimated with the aid of SigmaPlot (version 8.02; SPSS, Chicago, IL, U.S.A.), which uses a least-squares principle based on an established algorithm.
Agents NaNO 2 (Wako Pure Chemical Industries, Osaka, Japan) was dissolved in saline (Otuka, Tokyo, Japan). All other chemicals were of analytical grade or of the highest grade commercially available.
Statistical Analysis All data are expressed as meanϮthe standard error of the mean (S.E.M.). Within-group comparisons were made with paired Student's t-tests, and betweengroup comparisons were performed with unpaired Student's t-tests. For repeated measures, or for more than three groups, comparisons were made by one-or two-way analysis of variance (ANOVA) followed by Tukey's method. Differences were considered significant at pϽ0.05.
RESULTS

Disappearance of Endogenous and Exogenous NO 2
؊ ؊ from Plasma ex Vivo Blood samples were drawn from rabbits and were immediately followed by ex vivo sampling procedures before and 0.5, 3, 15, and 30 min after vehicle (protocol A) or NaNO 2 (protocol B) administration. Although treatments were performed immediately after sampling, in a preliminary experiment we noticed that plasma NO 2 Ϫ levels could decrease during sample processing from blood sampling to plasma separation. We therefore measured the exact time duration from sampling to plasma separation of the blood sample (60-90 s), and used this time measure for further plotting and analysis of NO 2 Ϫ levels. In the vehicle control study (protocol A), a small but significant time-dependent decrease in NO 2 Ϫ concentration was observed in both arterial and venous plasma; however, no significant changes in plasma NO 3 Ϫ concentration or hemolysate NO x concentration were detected (Fig. 2 , upper parts). Thus, there was no significant linear relationship between NO 2 Ϫ and NO 3 Ϫ concentrations in arterial plasma (rϭ0.17, pϭ0.37) or in venous plasma (rϭ0.09, pϭ0.62). When NaNO 2 was added to a final concentration of 6 mM in whole blood (protocol B), the whole-blood (hemolysate) NO x concentration increased to approximately 6 mM, as expected. NO x levels in arterial hemolysate remained stable thereafter, but venous hemolysate NO x levels tended to decrease without statistical significance after 15 min (Fig. 2 , middle parts). Plasma NO 2 Ϫ levels increased over 6 mM in both arterial and venous blood, and decreased exponentially, accompanied by a reciprocal increase in NO 3 Ϫ plasma levels. Fig. 3 ). How- ever, the rate of disappearance of NO 2 Ϫ from arterial plasma differed from that in venous plasma (t 1/2 was ca. 12 min in arterial blood and ca. 8 min in venous blood), regardless of the initial NO 2 Ϫ concentration, as long as the blood was isolated from in vivo circulation (Fig. 3) . Additionally, when samples were handled swiftly and measured NO 2 Ϫ concentrations were corrected with the exact time until plasma separation and respective k el s, no A-V difference was detectable at time 0 (Table 1) , indicating no difference in the apparent volume of distribution between isolated arterial and venous blood.
We also investigated ex vivo disappearance of NO 2 Ϫ after in vivo loading of NaNO 2 (0.1 ml/kg of 5 mM NaNO 2 in saline, intravenously (i.v.)) in the anesthetized rabbits (protocol C). Thirty seconds after exogenous NO 2 Ϫ , blood samples were isolated from in vivo circulation and were analyzed as described above. Plasma NO 2 Ϫ , plasma NO x , and hemolysate (whole blood) NO x levels increased over time (Fig. 2 , lower parts). However, the degrees of change were smaller than those observed following NO 2 Ϫ addition to isolated blood ( Fig. 2 , middle parts), and the increases in arterial blood were significantly larger than those in venous blood (Fig. 2 , lower parts). NO 2 Ϫ levels then decreased time-dependently, and the estimated NO 2 Ϫ concentration at time 0 was significantly different between arterial and venous blood samples only in this protocol C (Fig. 3 , Table 1 ). The rate of NO 2 Ϫ decrease in plasma (k el ) following in vivo loading was similar to the rate observed in the ex vivo experiments, and its significant A-V difference was also detected. A reciprocal increase in NO 3 Ϫ concentration was also observed in this situation (Fig. 2 Arterial and venous blood samples were incubated at 37°C ex vivo and vehicle (saline; protocol A, upper part) or NaNO 2 (6 mM in whole blood; protocol B, middle part) was loaded. Changes in blood NO x concentration after in vivo NO 2 Ϫ injection (500 nmol/kg) followed by ex vivo incubation (protocol C, lower part) is also shown. Samples were lysed in hypotonic solution for whole-blood NO x measurement or centrifuged for plasma separation followed by plasma NO 2 Ϫ and NO 3 Ϫ quantification (plasma samples were taken at the indicated time points The data depicted in Fig. 3 were analyzed with a one-compartment open model (yϭC 0 ϫexp(Ϫk el ϫt)), where y is the NO 2 Ϫ concentration, C 0 is the estimated NO 2 Ϫ concentration at time 0, k el is the elimination constant, and t is the time at plasma separation. * Significantly different from arterial blood within a protocol. Data (nϭ6 at each value) were analyzed by two-way ANOVA followed by Tukey's method.
2.4 mmHg at time 0) and heart rate (307Ϯ12 beats/min at time 0) did not change significantly over the course of the experiment (Fig. 4) . There was also no significant difference in plasma NO 3 Ϫ concentration in arterial (38.7Ϯ2.7 mM) versus venous blood (39.8Ϯ3.0 mM) at time 0. Neither arterial nor venous NO 3 Ϫ concentrations significantly increased after the NO 2 Ϫ injection, but both decreased after 30-60 min (pϽ0.05) from the respective control values. The plasma NO x (NO 2 Ϫ ϩ NO 3 Ϫ ) concentration increased by 4.21Ϯ0.87 mM in arterial blood and 2.23Ϯ0.58 mM in venous blood after NO 2 Ϫ injection, followed by a tendency to decrease (Fig. 4) . This transient increase after NO 2 Ϫ injection was also observed in whole blood (hemolysate) NO x (1.82Ϯ0.91 mM in arterial blood and 1.74Ϯ0.62 mM in venous blood) followed by a small, but significant decrease (Fig. 4) ) and in hemolysate were not strongly affected by the length of duration of the sample treatment, NO 2 Ϫ levels were clearly sensitive to time before plasma separation, and a precise NO 2 Ϫ value was required for further examination of NO 2 Ϫ kinetics. Therefore, the time from blood sampling to plasma separation was measured, and the decay of plasma NO 2 Ϫ was calculated with k el (61.1ϫ 10
Ϫ3
/min for arterial blood and 86.4ϫ10 Ϫ3 /min for venous blood, taken from the in vivo loading experiment; Table 1) for each sampling procedure to correct the NO 2 Ϫ concentration at the sampling time points.
Following this correction, the estimated arterial plasma NO 2 Ϫ levels (781Ϯ139 nM) were not significantly different from the levels in venous plasma (795Ϯ135 nM) at time 0 (steady-state). After the injection, arterial and venous NO 2 Ϫ concentrations increased markedly, followed by exponential decreases. Significant A-V differences (pϽ0.05) were detected at 0.5 and 3 min. The NO 2 Ϫ levels stayed significantly (pϽ0.05) higher than the respective control levels even after 30 min had elapsed (1199Ϯ158 nM for arterial plasma and 1242Ϯ148 nM for venous plasma).
When differences from the control values were plotted against time, the distribution phase and the elimination phase were clearly distinguishable (Fig. 5) , prompting the application of a two-compartment model for further analysis. The hybrid parameters (see 'Kinetic Analysis' in Materials and Methods) obtained by curve fitting were 3717Ϯ204 nM and 1187Ϯ205 nM (pϽ0.05 by unpaired t-test) for arterial and venous A, respectively, and 1281Ϯ101 nM and 1372Ϯ116 nM for arterial and venous B, respectively. When exogenous NO 2 Ϫ only distributes to the circulating blood, A is expected to be ca. 6250 nM, based on the assumption that the volume of circulating blood is 8% of body weight, as observed in the ex vivo loading of NaNO 2 (Fig. 2) . Arterial and venous a were 0.63Ϯ0.02 and 0.48Ϯ0.08/min, respectively, and b was 0.036Ϯ0.006/min for arterial blood and 0.036Ϯ0.007/min for venous blood. There was no significant difference in the half-lives of the elimination phases of arterial and venous plasma NO 2 Ϫ (Table 1) . Microscopic parameters were calculated based on the hybrid parameters above (Table 2) ; the volume of distribution of the arterial central compartment (Vd 1 ) was significantly smaller than that of the venous compartment, and the reverse scenario was found in the peripheral compartments (Vd 2 ). However, the volume of distribution at steady-state (Vd ss ϭ Vd 1 ϩVd 2 ) in the arterial system was very similar to that found in the venous system ( Table 2 ). The rate constant from the central compartment to the peripheral compartment (k 12 ) tended to be larger in arterial blood than in venous blood, and the reverse tendency was detected in the reverse direction (k 21 ), although it was not statistically significant ( Table 2) . The elimination constant (k el ) in the arterial system was significantly larger than in the venous system; however, the estimated total clearances (CL total ϭD/(A/aϩB/b); 0.098 l/kg/h) were similar to each other.
To figure out a concrete idea of contribution of tissue as a major element of the peripheral compartment (Vd 2 ), data from the in vivo NO 2 Ϫ loading experiment (the kinetic experiment) were overlaid on the data from the ex vivo, isolated blood experiment (Fig. 6 ). Abrupt increases in plasma NO 2 Ϫ concentration above 6 mM in both arterial and venous blood indicate that increases in the NO 2 Ϫ concentration in RBCs are rather small. The difference between the higher level of plasma NO 2 Ϫ in isolated blood and the lower level in circulating blood indicates the rapid transfer of NO 2 Ϫ from blood to tissue, while the transfer from tissue to blood occurs in venous blood when plasma NO 2 Ϫ levels in isolated blood decrease below the control level.
Extrapolation to Possible Metabolic Pathways Underlying the A-V Difference Changes in the metHb content of arterial and venous blood were examined as a possible source of the A-V difference. Intravenous delivery of 500 nmol/kg of NaNO 2 affected neither heart rate nor mean blood pressure in anesthetized rabbits (Fig. 7, left) . There were no A-V differences in Hb and metHb levels at steady-state (0 min), and these levels did not change significantly after the injection (Fig. 7, left ). An extremely high dose of NaNO 2 (150 mmol/ kg) significantly decreased the mean blood pressure for 60 min without significant affecting the mean heart rate (Fig. 7,  right) . After this intervention, the metHb content of the arterial and venous blood samples markedly and significantly increased, without a detectable A-V difference (Fig. 7, right) . Although the changes in metHb seemed to mirror the changes in mean blood pressure, no significant linear relationship was detected in arterial blood (rϭϪ0.165, pϭ0.387) or venous blood (rϭϪ0.161, pϭ0.399).
The existence of and changes in R-SNOs were examined in a separate set of experiments in rabbits. First, 500 nmol/kg of NaNO 2 were intravenously injected into six rabbits (2.8Ϯ 0.1 kg). R-SNOs were absent in the control condition (time 0), and no trace amounts of the substances were detected after 0.5 and 15 min of NO 2 Ϫ loading. There were no signifiApril 2011 533 Ϫ loading (protocol B in Fig. 2 ) are superimposed onto the data taken from the whole-animal experiment in which NO 2 Ϫ was intravenously (500 nmol/kg) injected and blood samples were taken at the indicated time points (Figs. 4, 5) . The injection dose was designed to be nearly equivalent to the ex vivo experiment (6 mM), when circulating blood is estimated to be ca. 8% of body weight (ca. 6 mM in whole blood, when exogenous NO 2 Ϫ is assumed to be distributed solely in circulating blood). Differences in NO 2 Ϫ concentrations between the in vivo and ex vivo experiments may indicate an overall shift in NO 2 Ϫ concentration between blood and tissue. Fig. 7 . Changes in Heart Rate, Blood Pressure, and metHb Concentration after in Vivo NaNO 2 Loading cant changes in mean blood pressure (96.3Ϯ10.6 mmHg at time 0) and heart rate (311Ϯ8 beats/min at time zero) during the course of the experiment. An extremely high dose of NO 2 Ϫ (150 mmol/kg: 0.2 ml/kg of 0.75 M NaNO 2 solution) was administered intravenously to a second group of six rabbits (2.9Ϯ0.1 kg). Both heart rate (302Ϯ3 beats/min at time 0) and mean blood pressure (109.0Ϯ4.2 mmHg) significantly (pϽ0.05) decreased 15 min after administration to 278Ϯ 4 beats/min and 73.5Ϯ7.6 mmHg, respectively. However, no R-SNOs were detected at 0 min, 0.5 min, or 15 min after injection of the high dose of NaNO 2 .
Steady-State NO 2 ؊ ؊ Concentration and A-V Difference after NO 2 ؊ ؊ Loading in Rats and Guinea Pigs Treatment of rats and guinea pigs was employed to examine speciesdependent A-V differences in plasma NO 2 Ϫ levels at steady state and after NO 2 Ϫ loading. Since frequent blood sampling in rats is hindered by the small volume of circulating blood, the rats were divided into two groups. Similar to the in vivo loading experiment performed in rabbits (similar to protocol C in Fig. 1 ), NO 2 Ϫ (500 nmol/kg; 0.1 ml/100 g of 0.5 mM solution) was intravenously administered to the first group of rats (nϭ6), and arterial and venous blood samples (800 ml each) were taken after 30 s. Half of each sample was processed immediately for measurements of arterial and venous plasma NO 2 Ϫ concentrations (1.77Ϯ0.20 mM and 1.51Ϯ 0.19 mM, respectively); the remaining volume was kept at 37°C for 10 min, then measured for arterial and venous plasma NO 2 Ϫ concentrations (0.79Ϯ0.12 mM and 0.41Ϯ0.05 mM, respectively). According to a one-compartment model, the k el of arterial plasma (0.0827Ϯ0.0127/min) was significantly (pϽ0.01) smaller than the k el of venous plasma (0.1314Ϯ0.0092/min); the mean values were used for data correction in the second experiment. In the second group of rats, control blood sampling for assessment of steady-state NO 2 Ϫ levels was followed by NO 2 Ϫ loading, and the next sample was taken 30 s later (sample volume ca. 380 ml each). After k el correction, no A-V difference was evident in steadystate NO 2 Ϫ concentrations, but a significant A-V difference appeared immediately after NO 2 Ϫ loading (Fig. 8) . Wholeblood NO x concentrations (hemolysate NO x ) of arterial and venous blood (9.05Ϯ0.84 mM and 9.59Ϯ0.72 mM, respectively) significantly (pϽ0.05) increased by ca. 2 mM (11.75Ϯ 0.70 mM in arterial blood and 10.58Ϯ0.84 mM in venous blood) following NO 2 Ϫ loading; however, no A-V differences in whole blood NO x were detected prior to injection or 30 s after NO 2 Ϫ loading. The same loading procedure was applied to guinea pigs (nϭ6); k el s of 0.0777Ϯ0.0092/min for arterial plasma NO 2 Ϫ and 0.1310Ϯ0.0137/min for venous plasma NO 2 Ϫ (significantly larger than that of arterial blood; pϽ0.01) were obtained from samples taken 30 s after loading (2.39Ϯ0.16 mM and 1.57Ϯ0.22 mM for arterial and venous plasma NO 2 Ϫ concentrations, respectively) and from samples kept another 10 min ex vivo at 37°C (1.10Ϯ0.07 mM and 0.46Ϯ0.10 mM for arterial and venous plasma NO 2 Ϫ concentrations, respectively). Similar to the results obtained from rats, the second group of guinea pigs (nϭ6) exhibited no A-V difference in steady-state NO 2 Ϫ concentration, but did possess significant A-V differences immediately after NO 2 Ϫ loading (Fig. 8 ). There was no significant A-V difference in whole-blood NO x levels at time 0 (47.64Ϯ6.20 mM in arterial blood and 46.48Ϯ 5.46 mM in venous blood) and after NO 2 Ϫ loading (49.70Ϯ 5.63 mM in arterial blood and 49.00Ϯ5.65 mM in venous blood), although the latter measurement was significantly (pϽ0.05) different from the control condition (time 0).
Changes in NO 2 ؊ ؊ Concentration Under Different Oxygenation States of ex Vivo Blood The oxygenation states of arterial and venous blood samples were altered by equilibration with a regulated gas phase in the headspace of the sample tubes (Table 3) . Plasma NO 2 Ϫ levels significantly decreased in arterialized venous blood with similar oxygen partial pressure (P O 2 ) as the original arterial blood sample, and a similar decrease was observed in the venous blood equilibrated with argon gas. Decreasing the oxygen level of arterial blood to a level similar to the original venous blood level decreased plasma NO 2 Ϫ levels to an extent similar to the decrease following identical treatment of the venous blood sample. Only hyperoxygenation of arterial blood failed to significantly decrease plasma NO 2 Ϫ levels (Fig. 9) . These changes seemed reciprocal to changes in plasma NO 3 Ϫ levels (Fig. 9) ; however, there was no significant relationship between changes in plasma NO 2 Ϫ and NO 3 Ϫ levels (rϭ0.36, pϭ Blood samples were taken before and 30 s after intravenous NO 2 Ϫ injection (500 nmol/kg; 0.1 ml/kg of 5 mM NaNO 2 solution). Plasma NO 2 Ϫ levels of circulating arterial and venous blood (time 0) were estimated by k el s obtained from other experiments (see text for details). Mean blood pressure (117.9Ϯ9.6 mmHg at time 0) and heart rate (428Ϯ28 beats/min at time 0) of 6 rats (310Ϯ9 g) were not significantly affected by NO 2 Ϫ injection. Similarly, there were no significant changes in mean blood pressure (44.1Ϯ7.3 mmHg at time 0) and heart rate (303Ϯ22 beats/min time 0) after intravenous NO 2 Ϫ treatment of 6 guinea pigs (350Ϯ34 g). For comparison, result obtained from rabbits (in vivo kinetic study mostly presented in Figs. 4 and 5) is also shown. * * Significantly (pϽ0.01) different from arterial plasma levels by paired t-test. (Fig. 9 ). Only the original arterial blood kept under higher oxygen tension maintained its NO 2 Ϫ level; its metabolic or kinetic destination could not be solely NO 3 Ϫ , but must involve other unknown compartments.
DISCUSSION
Ex Vivo Study of NO 2
؊ ؊ Disappearance from Plasma We observed different rates of NO 2 Ϫ disappearance from arterial and venous plasma after blood sampling (Table 1, Fig. 3 ), a phenomenon that may be the cause of the apparent A-V difference in steady-state plasma NO 2 Ϫ concentrations. Plasma NO 2 Ϫ is known to disappear rapidly even at 4°C, although it is stable for a long periods after separation from the cellular compartment. 27, 28) The majority of the cellular effect is due to RBCs; NO 2 Ϫ uptake is achieved through the activity of the anion exchanger AE1, as well as through simple diffusion of HNO 2 followed by intracellular metabolic processes. 29) The rate of NO 2 Ϫ disappearance from plasma has been reported to be dependent on the oxygenation state of the blood 8, 15) : the lower the oxygenation level (venous blood), the faster the disappearance occurs. 30) Evidence of faster NO 2 Ϫ uptake by RBCs under physiological venous oxygen saturation levels than under physiological arterial oxygen saturation levels has been recently reported in rabbits, 29) humans, 31) and fish, 15) observations that are in good accordance with our present A-V difference in k el . Ex vivo NO 2 Ϫ half-lives are reported to be 12 min in pig blood 32) and 11 min in human RBC suspensions, 28) similar to our findings of 12 min for arterial plasma and 8.3 min for venous plasma (Table 1) .
Previous studies have not called attention to the duration of sample handling as a source of measurement error. We have clearly demonstrated that the k el of plasma NO 2 Ϫ differs between arterial and venous blood ex vivo, and that the arterial and venous k el s are not affected by the initial NO 2 Ϫ levels of the samples (Table 1, Fig. 3) . Therefore, the duration of time between blood sampling and plasma separation may be a major determinant of plasma NO 2 Ϫ levels in arterial and venous blood, and may also be a cause of the apparent A-V difference in plasma NO 2 Ϫ levels under steady-state conditions. Indeed, when sample processing was minimized and the measurements were corrected with the respective time durations and k el s, the A-V difference was no longer detectable (Table 1, Fig. 3 ). In our previous study, 10) the processing duration was ca. 8 min (estimated retrospectively); the mean plasma NO 2 Ϫ levels (751Ϯ107 nM in arterial blood and 624Ϯ78 nM in venous blood, pϽ0.05 by paired t-test) became similar to each other when roughly corrected by the k el s and 8-min duration (1224 nM for arterial blood and 1246 nM for venous blood). Conversely, when plasma separation was performed after 8 min of sampling in the present work, the estimated values resulted in a statistically significant A-V difference (525Ϯ85 nM in arterial blood and 437Ϯ 68 nM in venous blood, pϽ0.05 by paired t-test).
Studies reporting A-V differences in plasma NO 2 Ϫ levels at steady-state included a centrifugation step of 5-10 min for plasma separation 4, 11, 12) and are comparable to the ca. 8 min from blood sampling observed by us previously. 10, 14) Therefore, rapid sample processing is critical for more accurate estimation of plasma NO 2 Ϫ levels. We applied an identical procedure to rats and guinea pigs to examine whether species differences impact the evaluation of plasma NO 2 Ϫ concentrations under steady-state conditions. No A-V difference was observed in these species (Fig. 8) , supporting our hypothesis that the difference results from processing time duration and an A-V difference in k el .
In the present ex vivo studies (Fig. 2) , the decreases in loaded NO 2 Ϫ in arterial and venous plasma were accompanied by reciprocal increases in NO 3 Ϫ , with the respective regression lines carrying different slopes. Whole-blood NO x levels did not significantly change in these protocols. Therefore, the difference in blood oxygenation state (ratio of oxygenated to deoxygenated Hb) may contribute to the different regression lines or NO 3 Ϫ formation in arterial and venous blood. 1, 33) A complex autocatalytic mechanism such as oxidization of NO 2 Ϫ to NO 3 Ϫ may occur in fully oxygenated RBCs, while NO The oxygenation states of arterial and venous blood samples were significantly (pϽ0.05 by paired t-test against control conditions; nϭ9 for each sample) modified by equilibration with different gas phases. NO x concentrations were evaluated before and after the oxygenation-state changes. Cont, control (arterial and venous) blood just after sampling. a: Significantly (pϽ0.05) different from deoxygenated arterial blood, oxygenated and argon gas-equilibrated blood, by two-way ANOVA followed by Tukey's method. b: Significantly (pϽ0.05) different from deoxygenated arterial blood (P O 2 ϭ44.2Ϯ2.5 mmHg), by two-way ANOVA followed by Tukey's method. c: Significantly (pϽ0.05) different from oxygenated venous blood (P O 2 ϭ130.9Ϯ20.5 mmHg), by two-way ANOVA followed by Tukey's method.
formation by deoxygenated Hb and NO 2 Ϫ in fully deoxygenated RBCs would take place. However, in practice, some of the NO may be oxidized to NO 2 Ϫ under partially oxygenated physiological conditions. 30) Regarding plasma NO 2 Ϫ levels, however, the duration of time that passes before plasma separation is a major determinant of the apparent A-V difference under steady-state conditions. Although ex vivo addition of NO 2 Ϫ to isolated blood resulted in no A-V difference at time 0 (Protocol B in Fig. 3) , an apparent A-V difference was detected when NO 2 Ϫ was intravenously administrated to anesthetized animals even after the correction (protocol C in Fig. 3) . This difference may be attributable to NO 2 Ϫ transfer between plasma and tissue, 18) as will be discussed later. In Vivo Kinetics Corrected by Parameters Obtained in the ex Vivo Study We re-evaluated the in vivo kinetic parameters of NO 2 Ϫ with data corrected for the duration of time before plasma separation and corrected for k el (Table 2) . Here we report the following differences from our previous observations 10) : 1) Decreases in half-lives and consequent increases in k el s in arterial and venous plasma; 2) increases in volumes of central compartments (Vd 1 ) in both arterial and venous systems; 3) decreases in volumes of peripheral compartments (Vd 2 ) in both arterial and venous systems; 4) decreases in volume of distribution at steady state (Vd ss ) in both arterial and venous systems. These differences mainly derive from the higher venous NO 2 Ϫ concentrations after correction. However, the half-lives observed in the present study are still longer than those found in normoxic and hypoxic lams (8-9 min) 8) and even shorter than the 42.1 min reported in a study of healthy humans.
9) The accuracy of kinetic parameters derived from the NO 2 Ϫ loading experiment may be debatable, although this method is standard for kinetic analysis. Very rapid distribution of NO 2 Ϫ to the peripheral compartment would also serve as a confounding factor. In addition, the observed A-V difference after 30 s of exogenous NO 2 Ϫ loading (Figs. 2, 3 ) indicated that the A-V difference may result from rapid uneven NO 2 Ϫ distribution due to a possible fast interactive transfer of NO 2 Ϫ between tissue and plasma.
To our present knowledge, tissue and RBCs are the major constituents of the tissue compartment (Vd 2 ); the NO 2 Ϫ pool, R-SNOs, N-nitrosothiols, and NO-hem are implicated as possible kinetic or metabolic destinations. 19) The capacity-and time-dependent kinetics of the NO 2 Ϫ pool in RBCs may not be identical in arterial and venous blood.
34) The uptake of NO 2 Ϫ is very rapid, and a tendency for initial faster uptake by tissue (heart) under hypoxic conditions than under normoxic conditions has been suggested elsewhere. 19) In addition, a great contribution of tissue as a major component of peripheral compartment is suggested in this study (Fig. 6 ). This observation reflects the operation of a mechanism to maintain plasma NO 2 Ϫ concentrations at a certain low constant level, as was previously suggested. 18) These factors may substantially contribute to the initial A-V difference after in vivo exogenous NO 2 Ϫ administration. Thirty seconds, the interval to our first sampling, is sufficient for the interactive transfer, but we did not follow such rapid changes. More frequent blood sampling during the initial distribution phase may enable the more precise estimation of initial plasma NO 2 Ϫ concentrations in vivo. However, the sampling procedure employed here is most practical when the circulation time of 4.8-7.5 s in rabbits 35, 36) is taken into consideration. Since we have no practical method to elucidate the events that occur within this short period, the kinetic parameters estimated from the present experiments more closely approximate the true physiological values than previous reports, [8] [9] [10] but nonetheless still lack accuracy.
The initial drop in plasma NO 2 Ϫ levels after exogenous NO 2 Ϫ administration also resulted in a significant A-V difference in guinea pigs and in rats (Fig. 8) . Therefore, species differences were not detectable within the range we investigated.
Changes in NO 3 Ϫ levels were also detected in the present study. Although the increase in NO 3 Ϫ concentration was obvious in isolated blood, stability or even tendency to decrease was encountered in circulating blood. This phenomenon indicates that NO 2 Ϫ movement to other compartments and/or metabolic changes in NO 2 Ϫ are dominant in vivo, while oxidation of NO 2 Ϫ in isolated blood confirms the important role of tissue in NO 2 Ϫ physiology in vivo. Extrapolation to Possible Metabolic Pathways Underlying the A-V Difference In circulating blood, changes in RBC constituents (metabolic changes) and changes in soluble thiols (nitrosylation) might be detectable markers to follow metabolic pathways of exogenous NO 2 Ϫ . We evaluated these pathways for possible contributions of different oxygenation states to the observed A-V difference in NO 2 Ϫ concentration after NO 2 Ϫ loading.
2)
At a low dose (500 nmol/kg) of NO 2 Ϫ loading, neither NO 3 Ϫ levels nor metHb levels increased significantly, and neither high nor low molecular R-SNOs were detected (Fig. 7) . It is possible that a NO 3 Ϫ concentration several orders of magnitude larger than the NO 2 Ϫ basal values and their variations may cause a small increase in NO 3 Ϫ levels through NO 2 Ϫ oxidation, and unsaturated metHb reductase activity prevents accumulation of metHb. In addition, low NO 2 Ϫ concentrations would not activate autocatalysis of oxygenated Hb, 30) and a significant portion of NO 2 Ϫ would be metabolized through pathways that do not produce metHb. 8) In contrast, administration of a very high dose (150 mmol/kg) of NO 2 Ϫ increased metHb levels, with a concomitant decrease in blood pressure (Fig. 7) , suggesting reduction of NO 2 Ϫ by deoxygenated Hb to form metHb and NO. However, R-SNOs, a possible circulating reservoir of NO bioactivity, were not detected in this instance. Although the presence at steady-state and increase by NO or NO 2 Ϫ of R-SNO levels in plasma have been reported, 3, [37] [38] [39] the presence and pathophysiological role of circulating R-SNOs are still under debate, mainly due to methodological and technical concerns. 25, [40] [41] [42] The destination of the NO 2 Ϫ disappearing from the plasma is not clear, and is unlikely to be NO or other NO-bioactive carriers due to stable hemodynamics. NO 2 Ϫ may remain unchanged within RBCs or as nitroso-or other forms, 29, 30) as well as in tissues.
3) Our technical limitations did not permit further investigation of this outstanding question.
Changes in NO 2 ؊ ؊ Concentration Under Different Oxygenation States of ex Vivo Blood Though a possible contribution of small derangements in acid-base balance during treatments (decrease in P CO 2 and increase in pH) to the result may not be completely ruled out, it would be reasonable to mention as follows; Both a fall in and an elevation of oxy-genation level of venous blood resulted in a decrease in plasma NO 2 Ϫ levels (Fig. 9) . Oxygenation of venous blood to arterial levels may be sufficient to reduce plasma NO 2 Ϫ levels, since a decrease in the plasma NO 2 Ϫ level was confirmed in arterial blood in which the oxygen level was lowered to the venous level, while hyperoxygenation did not decrease plasma NO 2 Ϫ levels ( Fig. 9) , which is definitely different from other treatments. Oxygen-rich conditions in the arterial blood prevented decreases in plasma NO 2 Ϫ , suggesting that the decrease in NO 2 Ϫ concentration cannot be due to NO 3 Ϫ oxidation by oxyhemoglobin 43, 44) ; only oxygen-rich conditions or hyperoxygenation attenuated the disappearance of NO 2 Ϫ from plasma.
CONCLUSION
In summary, a faster rate of NO 2 Ϫ uptake by RBCs in venous blood than in arterial blood as well as extended sample handling times are possible causes of the apparent A-V difference in plasma NO 2 Ϫ under steady-state conditions. Measurements can be corrected by respective k el s and time durations, leading to an observation of equivalent levels of NO 2 Ϫ in arterial and venous plasma. However, when the NO 2 Ϫ concentration in circulating blood increases, the activity of tissue in buffering the change attenuates the increase in the plasma, especially in venous blood, inspiring caution in the interpretation of data under these circumstances.
